We are Sorry, This Page doesn't Exist
Pernix Therapeutics announces "successful closing" of contrave transaction
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pernix Therapeutics announces series of transactions
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
James E. Flynn reports 9.21% passive stake in Pernix Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pernix Therapeutics Reports Second Quarter 2018 Financial Results
MORRISTOWN, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialt.....»»
Pernix Therapeutics Holdings, Inc. (PTX) CEO John Sedor on Q2 2018 Results - Earnings Call Transcript
Pernix Therapeutics Holdings, Inc. (PTX) CEO John Sedor on Q2 2018 Results - Earnings Call Transcript.....»»
Pernix Therapeutics announces ruling in patent litigation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pernix Therapeutics Is In Real Trouble Here
Pernix Therapeutics Is In Real Trouble Here.....»»
Pernix Therapeutics" subsidiaries file appeal in litigation against Alvogen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A Setback for Solid Is a Win for Sarepta in Race to Treat Muscular Dystrophy
Sarepta Therapeutics solidified its position as the leader in developing a gene therapy for Duchenne muscular dystrophy following disappointing data from a clinical trial released Thursday......»»
Pernix Therapeutics: It Seems A Serious Sell
Pernix Therapeutics: It Seems A Serious Sell.....»»
Pernix Therapeutics enters asset purchase agreement with Highbridge for $75.6M
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mid-Afternoon Market Update: Jeld-Wen Rises On Earnings Beat; Pernix Therapeutics Shares Tumble
Toward the end of trading Tuesday, the Dow traded up 0.14 percent to 25,918.30 while the NASDAQ climbed 0.28 percent to 7,493.06. The S&P also rose, gaining 0.27 percent to 2,782.99. Leading and Lagging Sectors read more.....»»
Petri Dish: Non-viral vector startup launch; Foghorn’s new CFO
In this week’s Petri Dish we’ll take a look at a new Cambridge company founded by gene-editing experts that emerged with some big funding, as well as Foghorn Therapeutics’ new CFO and the awardees of $2.8 million in women's health funding......»»
Free F1 live stream: Where to watch every Formula 1 GP race weekend from anywhere
The new season is here, and we can help you find a free F1 live stream for all 24 races in the biggest Formula 1 championship yet. When you buy through our links, Business Insider may earn an.....»»
Salvage crews race against the clock to remove massive chunks of fallen Baltimore bridge
Salvage crews race against the clock to remove massive chunks of fallen Baltimore bridge.....»»
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
SOUTH SAN FRANCISCO, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) (NASDAQ:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported.....»»
Trump Vs. Biden: One Candidate"s Lead Narrows To Slim Margin Over Other
Recent polling data indicates a tightening race between President Joe Biden and former President Donald Trump as they gear up for a potential rematch in the upcoming election. read more.....»»
Biden Vs. Trump: Americans Rate Presidential Tenures, With Implications For 2024 Race
The American public is dissatisfied with both presidential candidates, explaining the close results in many opinion polls. read more.....»»
Breaking Down G1 Therapeutics: 5 Analysts Share Their Views
Latest Ratings.....»»
Why Aptevo Therapeutics Stock Is Cratering
Aptevo.....»»